Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Update: TiGenix Debuts In December After Motif Launched In November As 2016 Offerings Best 2015

Dec 14 2016

• By Mandy Jackson

stock

Related Content

Year's First 4 IPOs Go South As Proteostasis, AveXis Launch

Feb 13 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Motif Bio plc

AveXis, Inc.

Myovant Sciences Ltd.

Ra Pharmaceuticals, Inc.

CRISPR Therapeutics AG

Entero Therapeutics, Inc.

AC Immune SA

Novan, Inc.

Protagonist Therapeutics, Inc.

Gemphire Therapeutics, Inc.

Kadmon Holdings, Inc.

Astellas Gene Therapies

Syros Pharmaceuticals, Inc.

Selecta Biosciences, Inc.

Clearside Biomedical, Inc.

Moleculin Biotech, Inc.

Reata Pharmaceuticals, Inc.

Merus N.V.

PhaseRx, Inc.

Outlook Therapeutics, Inc.

Spring Bank Pharmaceuticals Inc.

Intellia Therapeutics, Inc.

Spyre Therapeutics, Inc.

Corvus Pharmaceuticals, Inc.

HUTCHMED (China) Limited

Syndax Pharmaceuticals, Inc.

Proteostasis Therapeutics, Inc.

Editas Medicine

BeOne Medicines Ltd.

Additional Topics

Commercial Financing StartUps and SMEs Strategy BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window